CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,179,608 | +156.0% | 624,259 | +215.7% | 1.08% | +146.9% |
| Q2 2023 | $6,709,929 | -55.5% | 197,758 | -52.8% | 0.44% | -54.5% |
| Q1 2023 | $15,089,904 | +1059.0% | 419,397 | +768.2% | 0.96% | +793.5% |
| Q2 2022 | $1,302,000 | -87.6% | 48,304 | -82.2% | 0.11% | -82.4% |
| Q4 2021 | $10,492,000 | +41.8% | 271,533 | +98.2% | 0.61% | +40.0% |
| Q3 2021 | $7,398,000 | +64.2% | 137,032 | +1.7% | 0.44% | +68.5% |
| Q2 2021 | $4,505,000 | – | 134,724 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |